Hospira Inc Press Releases

HSP 
$89.93
*  
0.01
0.01%
Get HSP Alerts
*Delayed - data as of Aug. 28, 2015  -  Find a broker to begin trading HSP now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    HSP After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By



Hospira Announces First Installation of Plum 360™ Infusion System With Hospira MedNet™
8/27/2015 10:30:00 AM - PR Newswire
▲0.01 % Price Change since this news event. The Volume Ratio is 0.68.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Hospira and Cerner Expand Agreement to Advance Integration of I.V.-EMR Technology
8/25/2015 9:25:00 AM - PR Newswire
▲0.03 % Price Change since this news event. The Volume Ratio is 1.92.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day






Charleston Area Medical Center Integrates Smart Pump Technology to Advance Patient Safety
8/20/2015 10:38:00 AM - PR Newswire
▲0.25 % Price Change since this news event. The Volume Ratio is 2.13.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


TGA Approves First mAb Biosimilar
8/19/2015 10:46:00 PM - PR Newswire
▲0.26 % Price Change since this news event. The Volume Ratio is 2.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day






Technical Briefing on Drugs - Generic Equities -- Hospira, Mallinckrodt, Momenta Pharma, Catalyst Pharma, and Lannett
8/7/2015 9:05:00 AM - PR Newswire
▲0.39 % Price Change since this news event. The Volume Ratio is 1.21.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Hospira Reports Second-Quarter 2015 Results
7/29/2015 7:30:00 AM - PR Newswire
▲0.78 % Price Change since this news event. The Volume Ratio is 0.76.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Hospira to Announce Second-Quarter 2015 Results on July 29, 2015
7/15/2015 4:03:00 PM - PR Newswire
▲0.65 % Price Change since this news event. The Volume Ratio is 1.2.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


NIRI-Chicago Elects 2015-2016 Officers and Directors
6/22/2015 10:35:00 AM - Business Wire


MetaStat, Inc. Announces Douglas A. Hamilton Named President, Chief Executive Officer
6/18/2015 8:00:00 AM - Business Wire
▲1.51 % Price Change since this news event. The Volume Ratio is 1.09.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


New results from first real-world study show comparable effectiveness and safety of Hospira's Inflectra™ (infliximab) in patients with rheumatic diseases switched from reference infliximab, Remicade™
6/10/2015 3:00:00 AM - PR Newswire
▲1.89 % Price Change since this news event. The Volume Ratio is 0.63.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


ANVISA Approves First Infliximab Biosimilar in Brazil
6/2/2015 10:00:00 AM - PR Newswire
▲1.72 % Price Change since this news event. The Volume Ratio is 1.23.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day